CHITA – a registry of in vitro NAMs
If we want to replace animal testing in biomedical research, how do we find human-relevant alternatives? It’s not that simple. There are 1000s of human cell-based assays and systems that…
If we want to replace animal testing in biomedical research, how do we find human-relevant alternatives? It’s not that simple. There are 1000s of human cell-based assays and systems that…
Whether you call them “Novel Alternative Methods”, “New Approach Methods”, or non-animal methods, NAMs research is gaining support at NIH. Biomedical researchers working to promote human-relevant science will be happy…
Overcoming Barriers to the Adoption of Human Alternatives to Animals in Biomedical Research FAIR data is data that is findable, accessible, interoperable, and reusable. Well, maybe it’s time for FAIR…
The NIH’s workshop on “Catalyzing the Development and Use of Novel Alternative Methods” brought together a diverse group of researchers and leaders to address one of the largest challenges in…
Precision medicine is the personalized approach to human disease that considers individual people’s differences in genetics, environment, and lifestyle. The goal of precision medicine is the right medicine to the…
Has FDA lost it’s way with NAMs? NAMs or New Alternative Methodologies is the term used by FDA for new regulatory tools to improve predictivity and help replace, reduce and/or…
Incorporating more relevant, human-based approaches (in vitro and in silico) in biomedical and toxicological research is a hot topic these days (see recent conferences organized by SOT, BioMed21, WC10, SACATM,…
